Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
48.9M
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
4.1M
-
Shares change
-
-134K
-
Total reported value, excl. options
-
$13.1M
-
Value change
-
-$306K
-
Put/Call ratio
-
2.88
-
Number of buys
-
12
-
Number of sells
-
-11
-
Price
-
$3.20
Significant Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q2 2018
41 filings reported holding AXSM - Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q2 2018.
Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.1M shares
of 48.9M outstanding shares and own 8.38% of the company stock.
Largest 10 shareholders include FMR LLC (982K shares), ROYCE & ASSOCIATES LP (888K shares), VANGUARD GROUP INC (581K shares), STIFEL FINANCIAL CORP (404K shares), Alethea Capital Management, LLC (271K shares), Sio Capital Management, LLC (193K shares), Opus Point Partners Management, LLC (134K shares), GEODE CAPITAL MANAGEMENT, LLC (94.2K shares), BRIDGEWAY CAPITAL MANAGEMENT INC (88K shares), and JPMORGAN CHASE & CO (81.7K shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.